首页> 外文OA文献 >Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration

【2h】

Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration

机译：Bevacizumab和Ranibizumab对新诊断的新生血管性黄斑变性的成本效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Joshua D. Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P. Lee; David W. Hutton;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration [J] . SteinJ.D., Newman-CaseyP.A., MrinaliniT., Ophthalmology . 2014,第4期

机译：贝伐单抗和兰尼单抗治疗新诊断的新生血管性黄斑变性的成本效益
2. COST-EFFECTIVENESS OF BEVACIZUMAB AND RANIBIZUMAB FOR NEWLY DIAGNOSED NEOVASCULAR MACULAR DEGENERATION (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS) [J] . Joshua D. Stein, Paula Anne Newman-Casey, Tavag Mrinalini, Transactions of the American Ophthalmological Society. . 2013,第Null期

机译：贝伐单抗和兰尼单抗治疗新诊断的脉络膜黄斑变性的成本效益（美国眼科学会论文）
3. Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration (An American Ophthalmological Society Thesis) [J] . Joshua D. Stein, Paula Anne Newman-Casey, Tavag Mrinalini, Transactions of the American Ophthalmological Society. . 2013,第1期

机译：贝伐单抗和雷珠单抗对新诊断的新生血管黄斑变性的成本效果（美国眼科学会论文）
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration (An American Ophthalmological Society Thesis) [O] . Joshua D. Stein, Paula Anne Newman-Casey, Tavag Mrinalini, 2013

机译：贝伐单抗和雷珠单抗对新诊断的新生血管黄斑变性的成本效益（美国眼科学会论文）
7. Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration [O] . David R. Griffin, Preston P. Richmond, John C. Olson 2014

机译：脊髓植酸的AfliBercept在持续性黄斑渗出物的患者中，以前用Bevacizumab和/或Ranibizumab用于新生血管年龄相关的黄斑变性

Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration

著录项

引文网络

相似文献

相关主题

期刊订阅